Reproductive function in men affected by X-linked adrenoleukodystrophy/ adrenomyeloneuropathy

European Journal of Endocrinology

Volumn 166, Issue 2, 2012, Pages 291-294

  Stradomska, T J ^a   Kubalska, J ^b   Janas, R ^a   Tylki Szymanska A ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; GAS CHROMATOGRAPHY; HETEROZYGOTE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MALE FERTILITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIGREE ANALYSIS; PRIORITY JOURNAL; SCREENING TEST; TESTOSTERONE BLOOD LEVEL;

ADRENOLEUKODYSTROPHY; ADULT; CHILD; CHILD OF IMPAIRED PARENTS; CHILD, PRESCHOOL; COHORT STUDIES; FATTY ACIDS, NONESTERIFIED; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; MARITAL STATUS; MIDDLE AGED; NUCLEAR FAMILY; REPRODUCTION; TESTOSTERONE; YOUNG ADULT;

EID: 84856108539     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0490     Document Type: Article

References (22)

1. Kemp S & Wander RJA. X-linked adrenoleukodystrophy: very-long-chain fatty acid metabolism. ABC half-transporters and the complicated route to treatment. Molecular Genetics and Metabolism 2006 90 268-276. (doi:10.1016/j.ymgme.2006.10.001)
2. Hudspeth MP & Raymond GV. Immunopathogenesis of adrenoleukodystrophy: current understanding. Journal of Neuroimmunology 2007 182 5-12. (doi:10.1016/j.jneuroim.2006.10.009)
3. van Geel BM, Assies J, Haverkort EB, Koelman JH, Vereeten B Jr, Wanders RJA & Barth PG. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil". Journal of Neurology, Neurosurgery and Psychiatry 1999 67 290-299. (doi:10.1136/jnnp.67.3.290)
4. Brennemann W, Kohler W, Zierz S & Klingmulle D. Testicular dysfunction in adrenomyeloneuropathy. European Journal of Endocrinology 1997 137 34-39. (doi:10.1530/eje.0.1370034)
5. Powers JM. The pathology of peroxisomal disorders with pathogenic considerations. Journal of Neuropathology and Experimental Neurology 1995 54 710-719. (doi:10.1097/00005072-199509000-00014)
6. Moser HW, Raymond GV & Dubey P. Adrenoleukodystrophy: new approaches to a neurodegenerative disease. Journal of the American Medical Association 2005 294 3131-3134. (doi:10.1001/jama.294.24.3131)
7. Stradomska TJ, Tylki-Szymańska A & Bentkowski Z. Very-long-chain fatty acids in Rett syndrome. European Journal of Pediatrics 1999 158 226-229. (doi:10.1007/s004310051055)
8. Libber SM, Migeon CJ, Brown FR & Moser HW. Adrenal and testicular function in 14 patients with adrenolekodystrophy or adrenomyeloneuropathy. Hormone Research 1986 24 1-8. (doi:10.1159/000180533)
9. Moser HW, Bergin A, Naidu S & Ladenson PW. Adrenoleukodystrophy. Endocrinology and Metabolism Clinics of North America 1991 20 297-318.
10. Assies J, Gooren LJ, van Geel B & Bart PG. Signs of testicular insufficiency in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy; a retrospective study. International Journal of Andrology 1997 20 315-321. (doi:10.1046/j.1365-2605.1997.00066.x)
11. Powers JM. Adreno-leukodystrophy (adreno-testiculo-leuko-myelo- neuropathic complex). Clinical Neuropathology 1985 4 181-199.
12. Whitcomb RW, Linehan WM & Knazek RA. Effect of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vivo. Journal of Clinical Investigation 1988 81 185-188. (doi:10.1172/JCI113292)
13. Bergmann M, Behr HM & Nieschlag E. Serum FSH and testicular morphology in male infertility. Clinical Endocrinology 1994 40 133-136. (doi:10.1111/j.1365-2265.1994.tb02455.x)
14. Powers JM & Schaumburg HH. A fatal cause of sexual inadequacy in men: adrenoleukodystrophy. Journal of Urology 1980 124 583-585. (Pubitemid 11195747)
15. Nenicu A, Lüers GH, Kovacs W, Bergmann M & Baumgart-Vogt E. Peroxisomes in human and mouse testis: differential expression of peroxisomal proteins in germ cells and distinct somatic cell types of the testis. Biology of Reproduction 2007 77 1060-1072. (doi:10.1095/biolreprod.107.061242)
16. Huyghe S, Schmalbruch HK, De Gendt K, Verhoeven G, Guillou F, van Veldhoven PP & Baes M. Peroxisomal multifunctional protein 2 is essential for lipid homeostasis in Sertoli cells and male fertility in mice. Endocrinology 2006 147 2228-2236. (doi:10.1210/en.2005-1571)
17. Baes M & Van Veldhoven PP. Generalised and conditional inactivation of Pex genes in mice. Biochimica et Biophysica Acta 2006 1763 1785-1793. (doi:10.1016/j.bbamcr.2006.08.018)
18. Moser AB, Kreiter N, Bezman L, Shou-en BS, Raymond GV, Sakkubai N & Moser HW. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 control. Annals of Neurology 1999 45 100-110. (doi:10.1002/1531-8249 (199901)45:1〈100::AID-ART16〉3.0.CO;2-U)
19. Stradomska TJ & Tylki-Szymańska A. VLCFA levels determined by gas chromatography in the diagnosis of peroxisomal disorders. Folia Neuropathologica 2009 47 306-313.
20. Aversa A, Palleschi S, Cruccu G, Silvestroni L, Isidori A & Fabbri A. Rapid decline of fertility in a case of adrenoleukodystrophy. Human Reproduction 1998 13 2474-2479. (doi:10.1093/humrep/13.9.2474)
21. Stradomska TJ & Tylki-Szymańska A. Decreasing serum VLCFA levels in ageing X-ALD female carriers. Journal of Inherited Metabolic Diseases 2001 24 851-857. (doi:10.1023/A:1013992224811)
22. Drosdzol A & Skrzypulec V. Evaluation of marital and sexual interactions of Polish infertile couples. Journal of Sexual Medicine 2009 6 3335-3346. (doi:10.1111/j.1743-6109.2009.01355.x)